Do you want to read an article? Please log in or register.
β-Blockers in COPD: A Cohort Study From the TONADO Research Program
COPD
COMMENTED
Related content
COPD
Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study
Eur J Clin Pharmacol.
Dong YH, Chang CH, Wu LC, Lai MS
doi: 10.1007/s00228-016-2097-y.
RECOMMENDED
COPD
Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Blervaque L, Préfaut C, Forthin H, Maffre F, Bourrelier M, Héraud N, Catteau M, Pomiès P, Jaffuel D, Molinari N, Hayot M, Gouzi F
doi: 10.1186/s12931-021-01674-3
COMMENTED
AsthmaCOPD
Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
Thorax.
Marcon A, Locatelli F, Keidel D, Beckmeyer-Borowko AB, Cerveri I, Dharmage SC, Fuertes E, Garcia-Aymerich J, Heinrich J, Imboden M, Janson C, Johannessen A, Leynaert B, Pascual Erquicia S, Pesce G, Schaffner E, Svanes C, Urrutia I, Jarvis D, Probst-Hensch NM, Accordini S; Ageing Lungs in European Cohorts (ALEC) study
doi: 10.1136/
AsthmaCOPD
Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey
Int J Chron Obstruct Pulmon Dis
Ding B, Small M
doi: 10.2147/COPD.S136314.
RECOMMENDED
COPD
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
Lancet Respir Med.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/S2213-
RECOMMENDED
COPD
Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.chest.2019.11.007.
RECOMMENDED
COPD
Safety and Tolerability of Comprehensive Research Bronchoscopy in COPD: Results from the SPIROMICS Bronchoscopy Sub-Study
Ann Am Thorac Soc.
Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, O'Beirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL
doi: 10.1513/AnnalsATS.
RECOMMENDED
COPDPneumonia
Real world effects of COPD medications: a cohort study with validation against RCT results
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I
doi: 10.1183/13993003.01586-2020. Visit the original publication at ncbi.nlm.nih.gov
AsthmaCOPDPneumonia
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study
Lancet Respir Med.
Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P
doi: 10.1016/